Stockreport

Immunic secures European patent for MS drug candidate vidofludimus calcium [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Tuesday the European Patent Office has granted a key patent covering dosing regimens for its experimental multiple sclerosis [Read more]